Progenity Stock Analysis

PROG -  USA Stock  

USD 1.28  0.04  3.23%

The big decline in price over the last few months for Progenitymay encourage shareholders to take a closer look at the company as it is trading at a share price of 1.28 on 14,694,614 in trading volume. The company directors and management failed to add value to investors and positioning the company supply of money to exploit market volatility in December. However, diversifying your holdings with Progenity or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 8.88. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Progenity partners.
Please check Your Equity Center.

Progenity Stock Analysis 

 
Refresh
The Progenity stock analysis report makes it easy to digest most publicly released information about Progenity and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Progenity Stock analysis module also helps to analyze the Progenity price relationship with some important fundamental indicators such as market cap and management efficiency.

Progenity Stock Analysis Notes

About 53.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.44. Progenity had not issued any dividends in recent years. Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company was founded in 2010 and is headquartered in San Diego, California. Progenity operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 265 people. To find out more about Progenity contact the company at 855 293 2639 or learn more at https://www.progenity.com.

Progenity Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Progenity's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Progenity or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Progenity generated a negative expected return over the last 90 days
Progenity has high historical volatility and very poor performance
Progenity may become a speculative penny stock
Progenity has high likelihood to experience some financial distress in the next 2 years
The company currently holds 157.83 M in liabilities. Progenity has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due.
The entity reported the previous year's revenue of 75.07 M. Net Loss for the year was (233.14 M) with loss before overhead, payroll, taxes, and interest of (19.12 M).
Progenity currently holds about 54.14 M in cash with (198.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.

Progenity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Progenity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Progenity backward and forwards among themselves. Progenity's institutional investor refers to the entity that pools money to purchase Progenity's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Cutler Group LpCall Options853.4 K321 K
Cutler Group LpCommon Shares49.1 K102 K
Cutler Group LpPut Options103.3 K94 K
Sargent Bickham Lagudis LlcCommon Shares30.00.0
Athyrium Capital Management LpCommon Shares36.4 M55.3 M
Neuberger Berman Group LlcCommon Shares6.5 M9.9 M
Vanguard Group IncCommon Shares926.1 K1.4 M
Renaissance Technologies LlcCommon Shares814.7 K1.2 M
Susquehanna International Group LlpCommon Shares783.8 K1.2 M
Note, although Progenity's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Progenity Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 247.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Progenity's market, we take the total number of its shares issued and multiply it by Progenity's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (121.42) % which means that it has lost $121.42 on every $100 spent on asset. This is way below average. Progenity management efficiency ratios could be used to measure how well progenity manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 24th of January, Progenity holds the risk adjusted performance of (0.07), and Coefficient Of Variation of (1,053). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Progenity, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Progenity, which can be compared to its competitors. Please check Progenity variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Progenity is priced some-what accurately, providing market reflects its current price of 1.28 per share. Given that Progenity is a hitting penny stock territory we advise to closely look at its total risk alpha.

Progenity Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Progenity price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator. View also all equity analysis or get more info about mesa adaptive moving average overlap studies indicator.

Progenity Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Progenity insiders, such as employees or executives, is commonly permitted as long as it does not rely on Progenity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Progenity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Howe Jill Ann over two months ago via Macroaxis 
Acquisition by Howe Jill Ann of 82879 shares of Progenity subject to Rule 16b-3
Hashemi Hutan over three months ago via Macroaxis 
Payment of 158 shares by Hashemi Hutan of Progenity subject to Rule 16b-3
Seelye Troy over three months ago via Macroaxis 
Payment of 23673 shares by Seelye Troy of Progenity subject to Rule 16b-3
Sarna Surbhi over six months ago via Macroaxis 
Acquisition by Sarna Surbhi of 96456 shares of Progenity subject to Rule 16b-3
Alter Jeffrey D over six months ago via Macroaxis 
Acquisition by Alter Jeffrey D of 51724 shares of Progenity subject to Rule 16b-3
Athyrium Capital Management Lp over six months ago via Macroaxis 
Purchase by Athyrium Capital Management Lp of 8097166 shares of Progenity
Athyrium Capital Management Lp over six months ago via Macroaxis 
Purchase by Athyrium Capital Management Lp of 961807 shares of Progenity
Hashemi Hutan over six months ago via Macroaxis 
Payment of tradable shares by Hashemi Hutan of Progenity subject to Rule 16b-3
Seelye Troy over six months ago via Macroaxis 
Payment of 1925 shares by Seelye Troy of Progenity subject to Rule 16b-3
Hashemi Hutan over six months ago via Macroaxis 
Acquisition by Hashemi Hutan of 24114 shares of Progenity subject to Rule 16b-3
Hashemi Hutan over six months ago via Macroaxis 
Acquisition by Hashemi Hutan of 24114 shares of Progenity subject to Rule 16b-3
Hashemi Hutan over six months ago via Macroaxis 
Acquisition by Hashemi Hutan of 4849 shares of Progenity subject to Rule 16b-3

Progenity Predictive Daily Indicators

Progenity intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Progenity stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Progenity Forecast Models

Progenity time-series forecasting models is one of many Progenity's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Progenity's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Progenity Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Progenity stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Progenity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Progenity. By using and applying Progenity Stock analysis, traders can create a robust methodology for identifying Progenity entry and exit points for their positions.
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company was founded in 2010 and is headquartered in San Diego, California. Progenity operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 265 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Progenity to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module
Please check Your Equity Center. Note that the Progenity information on this page should be used as a complementary analysis to other Progenity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Progenity Stock analysis

When running Progenity price analysis, check to measure Progenity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progenity is operating at the current time. Most of Progenity's value examination focuses on studying past and present price action to predict the probability of Progenity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Progenity's price. Additionally, you may evaluate how the addition of Progenity to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Is Progenity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progenity. If investors know Progenity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progenity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Progenity is measured differently than its book value, which is the value of Progenity that is recorded on the company's balance sheet. Investors also form their own opinion of Progenity's value that differs from its market value or its book value, called intrinsic value, which is Progenity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progenity's market value can be influenced by many factors that don't directly affect Progenity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progenity's value and its price as these two are different measures arrived at by different means. Investors typically determine Progenity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progenity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.